Martingale Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-17,202
Closed -$1.69M 1033
2018
Q2
$1.69M Sell
17,202
-8,100
-32% -$906K 0.02% 595
2018
Q1
$2.82M Sell
25,302
-8,800
-26% -$986K 0.04% 444
2017
Q4
$3.51M Sell
34,102
-1,600
-4% -$159K 0.05% 385
2017
Q3
$3.36M Sell
35,702
-6,200
-15% -$489K 0.05% 424
2017
Q2
$3.27M Sell
41,902
-1,000
-2% -$75.1K 0.05% 412
2017
Q1
$3.44M Hold
42,902
0.05% 395
2016
Q4
$3.38M Buy
42,902
+7,300
+21% +$567K 0.05% 422
2016
Q3
$2.78M Buy
+35,602
New +$2.58M 0.04% 423
2015
Q2
Sell
-6,957
Closed -$331K 925
2015
Q1
$331K Sell
6,957
-4,200
-38% -$186K 0.01% 772
2014
Q4
$483K Sell
11,157
-9,707
-47% -$397K 0.01% 704
2014
Q3
$718K Buy
20,864
+1
+0% +$35 0.02% 597
2014
Q2
$765K Sell
20,863
-2,802
-12% -$95.1K 0.02% 592
2014
Q1
$798K Buy
23,665
+907
+4% +$29.9K 0.03% 568
2013
Q4
$772K Sell
22,758
-2,001
-8% -$69.3K 0.03% 635
2013
Q3
$789K Hold
24,759
0.03% 620
2013
Q2
$560K Buy
+24,759
New +$536K 0.02% 714

Other funds holding CMD

Martingale Asset Management's CMD Position: Q3 2018 in Review

Martingale Asset Management sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 17,202 shares — an estimated $1.69M sold.

Martingale Asset Management first reported a position in CMD in Q2 2013 and held it in 16 quarters. The position peaked at $3.51M in Q4 2017. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • Martingale Asset Management reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • Martingale Asset Management sold 17,202 Cantel Medical Corporation shares in Q3 2018, an estimated $1.69M.
  • Martingale Asset Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 16 quarters.
  • Martingale Asset Management's Cantel Medical Corporation position peaked at $3.51M in Q4 2017.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Martingale Asset Management's 13F filing for Q3 2018, filed 9 Nov 2018.